2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid,
2-DACMPP,
efaproxiral,
RSR 13,
RSR 56,
RSR-13,
RSR-56,
RSR13,
RSR13 cpd,
Efaproxiral sodium,
170787-99-2,
Sodium 2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoate,
RSR13 SODIUM,
Efaproxiral (sodium),
RSR 13 sodium,
UNII-3L83QP52XI,
Efaproxiral sodium [USAN],
3L83QP52XI,
RSR-13,
AK116105,
Efaproxiral sodium, 98%,
Efaproxiral sodium (USAN),
Efaproxiral Sodium,
sodium 2-[4-[2-(3,5-dimethylanilino)-2-oxoethyl]phenoxy]-2-methylpropanoate,
2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid monosodium salt,
Propanoic acid, 2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methyl-, monosodium salt,
Revaproxyn,
efaproxiral-sodium,
Sodium 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methylpropanoate,
AC1MBG1O,
C20H22NNaO4,
SCHEMBL3763811,
CHEMBL2107744,
DTXSID50168942,
HMS3652L04,
BCP07458,
KS-00000G4N,
8768AA,
HY-13619A,
MFCD02093864,
s4263,
AKOS015896245,
AC-5019,
CS-4949,
AN-11377,
AX8127158,
FT-0084588,
FT-0658052,
ST24049208,
SW219343-1,
D03962,
A811239,
I06-2120,
2-(4((((3,5-Dimethylphenyl)amino)carbonyl)methyl)-phenoxy)-2-methyl propionic acid,
2-[4-[2-(3,5-dimethylphenylamino)-2-oxoethyl]phenoxy]-2-methylpropionic acid,
sodium 2-[4-[2-(3,5-dimethylanilino)-2-oxo-ethyl]phenoxy]-2-methyl-propanoate,
sodium,2-[4-[2-(3,5-dimethylanilino)-2-oxoethyl]phenoxy]-2-methylpropanoate,
sodium;2-[4-[2-(3,5-dimethylanilino)-2-oxoethyl]phenoxy]-2-methylpropanoate,
2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid monosodium salt,
2-[4-[2-[(3,5-dimethylphenyl) amino]-2-oxoethyl]phenoxy]-2-methylpropanoic acid monosodium salt,
sodium 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxidanylidene-ethyl]phenoxy]-2-methyl-propanoate,
Efaproxiral,
Efaproxyn,
RSR13,
Efaproxiral sodium [USAN],
C20H23NO4.Na,
C20-H23-N-O4.Na,
CID151175,
ACN-040169,
CID2725048,